Author:
Abovyan Aida,Zilfyan Artashes
Abstract
The aim of the study was to compare the results of using eye drops (a beta-blocker) with the results of selective laser trabeculoplasty in ocular hypertension. The retrospective study was conducted among treatment-naïve patients of two clinics in Yerevan, Armenia, during a period from 2019 to 2022. The eligible participants were divided into two groups as follows: group 1 (85 eyes) with patients who received SLT once and group 2 (52 eyes) where the patients have applied a single type of eye drops. The patients were allocated to the groups taking into account their preferences; this corresponded to random sampling. The IOP measures taken after 1, 3, 6, and 12 months showed reduction for more than 20% each time compared to baseline data. The mean IOP reduction was not significantly different in both treatment groups. SLT, as an effective and convenient technique allowing avoidance of the side effects of eye drops and an issue of low compliance, can be recommended as a method of the first choice in primary prevention of glaucoma.